Targeting tyrosine kinases in ovarian cancer: small molecule inhibitor and monoclonal antibody, where are we now?
A Rendell, I Thomas-Bland, L McCuish, C Taylor… - Biomedicines, 2022 - mdpi.com
Ovarian cancer is one of the most lethal gynaecological malignancies worldwide. Despite
high success rates following first time treatment, this heterogenous disease is prone to …
high success rates following first time treatment, this heterogenous disease is prone to …
[HTML][HTML] Research progress in prognostic factors and biomarkers of ovarian cancer
S Liu, M Wu, F Wang - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and
prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is …
prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is …
[HTML][HTML] High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles
The need for more effective and precision medicines for cancer has pushed the exploration
of new materials appropriate for drug delivery and imaging, and alternative receptors for …
of new materials appropriate for drug delivery and imaging, and alternative receptors for …
Prognostic Significance of Platelet (PLT) and Platelet to Mean Platelet Volume (PLT/MPV) ratio during apatinib second-line or late-line treatment in advanced …
R Su, J Zhu, S Wu, H Luo, Y He - Technology in Cancer …, 2022 - journals.sagepub.com
Background: Apatinib has a certain efficacy for advanced esophageal squamous cell
carcinoma (ESCC). This study aimed to investigate the prognostic significance of platelet …
carcinoma (ESCC). This study aimed to investigate the prognostic significance of platelet …
Association between Platelet-Derived Growth Factor Receptor Alpha Gene Polymorphisms and Platelet-Rich Plasma's Efficiency in Treating Lateral Elbow …
A Jarosz, A Balcerzyk-Matić, J Iwanicka… - International Journal of …, 2024 - mdpi.com
Individual differences in the response to platelet-rich plasma (PRP) therapy can be observed
among patients. The genetic background may be the cause of this variability. The current …
among patients. The genetic background may be the cause of this variability. The current …
[HTML][HTML] 血小板及其参数联合肿瘤标志物术前鉴别肝细胞癌及肝内胆管癌的临床价值
张浩东， 魏丰贤， 张春芳， 徐小东 - 肿瘤防治研究, 2022 - html.rhhz.net
目的探讨血小板(PLT) 及其参数和甲胎蛋白(AFP), 糖类抗原199 (CA199), 糖类抗原125
(CA125) 及癌胚抗原(CEA) 在术前肝细胞癌(HCC) 及肝内胆管癌(ICC) 鉴别诊断中的价值 …
(CA125) 及癌胚抗原(CEA) 在术前肝细胞癌(HCC) 及肝内胆管癌(ICC) 鉴别诊断中的价值 …
Development and Validation of a Combined Ferroptosis and Immune Prognostic Model for Melanoma
M Tang, Y Li, F Wang, J Han, Y Gao - Journal of Oncology, 2022 - Wiley Online Library
Background. Melanoma development and progression are significantly influenced by
ferroptosis and the immune microenvironment. However, there are no reliable biomarkers …
ferroptosis and the immune microenvironment. However, there are no reliable biomarkers …
[PDF][PDF] 血小板相关参数对胶质瘤患者预后的影响
刘长春， 付亮， 王文浩 - 国际神经病学神经外科学杂志, 2023 - jinn.org.cn
目的探讨术前血小板相关参数对胶质瘤患者肿瘤复发的预测作用. 方法分析联勤保障部队第九〇
九医院2015—2017 年收治的93 例胶质瘤患者临床病理资料, 根据随访期间肿瘤是否复发分为 …
九医院2015—2017 年收治的93 例胶质瘤患者临床病理资料, 根据随访期间肿瘤是否复发分为 …
[HTML][HTML] JAK/STAT 信号通路在卵巢高级别浆液性癌中的激活及预后意义
杨菁， 杜娟， 王玉湘， 刘从容 - Journal of Peking University (Health …, 2023 - ncbi.nlm.nih.gov
目的Janus 激酶(Janus kinase, JAK)、 信号转导和转录活化因子(signal transducers and
activators of transcription, STAT) 构成的JAK/STAT 信号通路的活化与卵巢高级别浆液性癌 …
activators of transcription, STAT) 构成的JAK/STAT 信号通路的活化与卵巢高级别浆液性癌 …
Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis
BM Vastrad, CM Vastrad - bioRxiv, 2024 - biorxiv.org
Endometriosis is a common cause of endometrial-type mucosa outside the uterine cavity
with symptoms such as painful periods, chronic pelvic pain, pain with intercourse and …
with symptoms such as painful periods, chronic pelvic pain, pain with intercourse and …